Sher Karki

Sher Karki has over two decades of experience in the biotechnology and pharmaceutical industries, with a significant tenure at Xencor from March 2001 to March 2025, where positions held include Executive Director, Senior Director, Director of Bioanalytical Development, Group Leader, Lead Scientist, and Scientist. Prior experience includes roles at Astellas Pharma from January 2010 to January 2018, serving as Associate Director, Assistant Director, and Senior Manager. Academic background includes a Ph.D. in Cell & Molecular Biology from the University of Pennsylvania School of Medicine (August 1992 - December 1997) and introductory coursework in Finance, Economics, and Management at The Wharton School (January 1998 - December 2001).